Ignite Creation Date:
2024-05-06 @ 9:21 AM
Last Modification Date:
2024-10-26 @ 12:13 PM
Study NCT ID:
NCT02968875
Status:
COMPLETED
Last Update Posted:
2018-05-29
First Post:
2016-09-07
Brief Title:
Alzheimers Disease and Physiological Cognitive Function and BDNF Levels of Plasma Adaptation After Exercise Training
Sponsor:
University Hospital Center of Martinique
Organization:
University Hospital Center of Martinique
Study Overview
Official Title:
Alzheimers Disease and Physiological Cognitive Function and BDNF Levels of Plasma Adaptation After Exercise Training
Status:
COMPLETED
Status Verified Date:
2018-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MARAE
Brief Summary:
Alzheimers disease AD is a neurodegenerative disease leading to one of the most common forms of dementia in humans and memory disorder is one of the first symptoms that lead to diagnosis
Detailed Description:
Present in greater amounts in the regions of the hippocampus and cortex the Brain-derived neurotrophic factor BDNF is essential to both learning and memory processes This protein is found in lower amounts in people with AD Acute physical activity of moderate to vigorous intensity would increase the levels of plasma BDNF whether for a healthy person or a person with AD Nevertheless in rest healthy people have higher level of BDNF than individuals with AD There are no studies on the effect of chronic exercise based on BDNF level at rest in people with AD In a hypothetical endurance training of 18 sessions whether interval or continuous training the levels of BDNF would increase in people with AD at rest Their physiological and neuropsychological performances would also show a rise
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None